methyl 3,4-dihydro-2H-chromen-6-ylacetate | 63476-14-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并吡喃
• 英文名称: methyl 3,4-dihydro-2H-chromen-6-ylacetate
• 英文别名: Chromanyl-6-essigsaeuremethylester；methyl 2-(3,4-dihydro-2H-chromen-6-yl)acetate
• CAS: 63476-14-2
• 化学式: C₁₂H₁₄O₃
• 分子量: 206.241
• InChiKey: ZSCRSZMNMPOWCS-UHFFFAOYSA-N

物化性质

• 沸点：
  309.5±11.0 °C(Predicted)
• 密度：
  1.145±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  15
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  methyl 3,4-dihydro-2H-chromen-6-ylacetate 在 lithium aluminium tetrahydride 作用下， 以 四氢呋喃 为溶剂， 反应 1.5h， 以97%的产率得到2-(3,4-dihydro-2H-chromen-6-yl)ethanol
  参考文献：
  名称：

  Discovery of DSP-1053, a novel benzylpiperidine derivative with potent serotonin transporter inhibitory activity and partial 5-HT1A receptor agonistic activity

  摘要：

  We have previously shown that SMP-304, a serotonin uptake inhibitor with weak 5-HT1A partial agonistic activity, may act under high serotonin levels as a 5-HT1A antagonist that improves the onset of paroxetine in the rat swimming test. However, SMP-304 is mostly metabolized by CYP2D6, indicating limited efficacy among individuals and increased side effects. To reduce CYP2D6 metabolic contribution and enhance SERT/5-HT1A binding affinity, we carried out a series of substitutions at the bromine atom in the left part of the benzene ring of SMP-304 and replaced the right part of SMP-304 with a chroman4-one. This optimization work led to the identification of the antidepressant candidate DSP-1053 as a potent SERT inhibitor with partial 5-HT1A receptor agonistic activity. DSP-1053 showed low CYP2D6 metabolic contribution and a robust increase in serotonin levels in the rat frontal cortex. (c) 2018 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2018.02.008
• 作为产物：
  描述：

  3-[4-(2-methoxy-2-oxoethyl)phenoxy]propanoic acid 在 甲醇 、 sodium tetrahydroborate 、 palladium 10% on activated carbon 、 氢气 、 对甲苯磺酸 作用下， 以 乙酸乙酯 、 苯 为溶剂， 反应 11.5h， 生成 methyl 3,4-dihydro-2H-chromen-6-ylacetate
  参考文献：
  名称：

  Discovery of DSP-1053, a novel benzylpiperidine derivative with potent serotonin transporter inhibitory activity and partial 5-HT1A receptor agonistic activity

  摘要：

  We have previously shown that SMP-304, a serotonin uptake inhibitor with weak 5-HT1A partial agonistic activity, may act under high serotonin levels as a 5-HT1A antagonist that improves the onset of paroxetine in the rat swimming test. However, SMP-304 is mostly metabolized by CYP2D6, indicating limited efficacy among individuals and increased side effects. To reduce CYP2D6 metabolic contribution and enhance SERT/5-HT1A binding affinity, we carried out a series of substitutions at the bromine atom in the left part of the benzene ring of SMP-304 and replaced the right part of SMP-304 with a chroman4-one. This optimization work led to the identification of the antidepressant candidate DSP-1053 as a potent SERT inhibitor with partial 5-HT1A receptor agonistic activity. DSP-1053 showed low CYP2D6 metabolic contribution and a robust increase in serotonin levels in the rat frontal cortex. (c) 2018 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2018.02.008

文献信息

• MAILLARD J.; LANGLOIS M.; DELAUNAY P.; VAN TRI VO; MEINGAN J.-P.; RAPIN M+, EUR. I. MED. CHEM., 1977,
  作者：MAILLARD J.、 LANGLOIS M.、 DELAUNAY P.、 VAN TRI VO、 MEINGAN J.-P.、 RAPIN M+

  DOI：——

  日期：——